Search for: "Teva Pharmaceuticals"
Results 921 - 940
of 1,430
Sorted by Relevance
|
Sort by Date
18 Jun 2013, 9:17 am
About 12 per cent of respondents were from Canadian companies.The survey shows corporate counsel seek to add value to the business by adopting new tactics to meet their goal, including:• Redefining strategies to obtain permits and regulatory approvals faster;• Planning for acquisitions before the business units engage in talks;• Sitting on research and development committees to spot IP opportunities earlier;• Developing settlement decision trees to get to resolution faster;… [read post]
9 May 2013, 5:34 am
The lawsuit names Pfizer, as well as two different generic drug manufacturers - Actavis Elizabeth and Teva Pharmaceuticals - in the U.S. [read post]
9 Jun 2014, 2:28 pm
He filed a drug defect case against Teva and Actavis, which are the two companies that made the generic drugs he took, and Wyeth, the maker of Reglan. [read post]
14 Jun 2013, 8:42 am
Further details may be obtained by emailing the KsIIP at kosovoip@gmail.com This Kat was thrilled to hear the news today that his friend Dr Galit Gonen, who heads up Teva's European litigation team, was voted ILO Global IP Counsel of the Year in New York last night. [read post]
3 Aug 2015, 4:01 pm
Remaining in the zone of patent law, PatLit carries a guest blog from the Wragge Lawrence Graham duo of Paul Inman and Andrew Maggs on inventive step and the role of the "obvious to try" test in Teva v Leo [Merpel posted on this very case yesterday, so now you have two commentaries to consider]. [read post]
5 Jun 2019, 2:37 pm
Teva Pharmaceuticals USA, Inc. [read post]
5 Jun 2019, 2:37 pm
Teva Pharmaceuticals USA, Inc. [read post]
17 Oct 2014, 12:00 am
On October 15, 2014, the Supreme Court heard arguments on the case of Teva Pharmaceuticals v. [read post]
18 Apr 2019, 1:57 pm
Teva Pharmaceuticals USA, Inc. [read post]
8 Sep 2023, 11:59 am
Injunctive relief protects the future," he said.New Mexico Opioids Trial Set the StageIn June 2023, LPR announced a $500-million settlement agreement with Walgreens, the pharmaceutical giant accused of recklessly dispensing opioids and, in so doing, facilitating the State of New Mexico's opioid crisis.The settlement news came after a two-month trial against pharmacy powerhouses Walgreens, Walmart, and Kroger. [read post]
18 Apr 2019, 1:57 pm
Teva Pharmaceuticals USA, Inc. [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in inequitable… [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
5 Dec 2008, 1:00 pm
You can separately subscribe to the Pharma & Biotech Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat) (Copyfight) (IAM) (Managing Intellectual Property) (Law360)… [read post]
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog) Diflucan… [read post]
13 Jul 2011, 3:04 am
(The SPC Blog) Doha+10: On November 14, 2011, a meeting at WIPO in Geneva to discuss the Doha Declaration (KEI) Docs at BIO: Session on IP challenges for personalised medicine (Patent Docs) France to reform its pharmaceutical regulatory system… with possible global implications! [read post]
28 Oct 2009, 7:15 am
(The SPC Blog) EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch) US: Time Magazine on data exclusivity debate (Patent Docs) US: BIO’s IPCC Conference: Behind the scenes look at patent cases – Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. [read post]
24 Jan 2012, 6:34 pm
Akorn’s ANDA, which FDA has not yet tentatively approved, contains a Paragraph IV certification to the ‘269 patent; however, according to the court, non-party Teva Pharmaceuticals USA, Inc. [read post]
28 Oct 2009, 6:15 am
(The SPC Blog) EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch) US: Time Magazine on data exclusivity debate (Patent Docs) US: BIO's IPCC Conference: Behind the scenes look at patent cases - Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. [read post]
28 Oct 2009, 6:15 am
(The SPC Blog) EU: European Federation of Pharmaceutical Industries and Associations unveils anti-counterfeit authentication system (IP Watch) US: Time Magazine on data exclusivity debate (Patent Docs) US: BIO's IPCC Conference: Behind the scenes look at patent cases - Mayo v Prometheus; Bilski v Doll; Laboratory Court of Am. [read post]
